NON-PROLIFERATIVE DIABETIC RETINOPATHY (NPDR)
Clinical trials for NON-PROLIFERATIVE DIABETIC RETINOPATHY (NPDR) explained in plain language.
Never miss a new study
Get alerted when new NON-PROLIFERATIVE DIABETIC RETINOPATHY (NPDR) trials appear
Sign up with your email to follow new studies for NON-PROLIFERATIVE DIABETIC RETINOPATHY (NPDR), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Ancient herb takes on diabetes eye disease: new trial underway
Disease control Not yet recruitingThis study tests whether a ginkgo biloba extract (EGb761) can slow or prevent diabetic retinopathy, a common eye complication of diabetes. Researchers will enroll 200 adults with long-standing diabetes and mild to moderate eye changes. Participants will either take the ginkgo sup…
Matched conditions: NON-PROLIFERATIVE DIABETIC RETINOPATHY (NPDR)
Phase: PHASE2 • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated May 17, 2026 09:04 UTC
-
New eye drops aim to slow diabetic retinopathy in small early trial
Disease control Not yet recruitingThis early-phase trial tests whether NPDR-01 eye drops can reduce tiny blood vessel bulges (microaneurysms) in the retina of people with non-proliferative diabetic retinopathy, a common complication of diabetes. Ten adults aged 18-75 with type 1 or type 2 diabetes will receive th…
Matched conditions: NON-PROLIFERATIVE DIABETIC RETINOPATHY (NPDR)
Phase: EARLY_PHASE1 • Sponsor: Sichuan Academy of Medical Sciences • Aim: Disease control
Last updated May 11, 2026 20:48 UTC